Evidence map›Paper›PMID 34977950›Full record

ReviewInternational urogynecology journal2022

International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs.

Heidi W Brown, Aparna Hegde, Markus Huebner, Hedwig Neels, Hayley C Barnes, Gisele Vissoci Marquini, Narmin Mukhtarova, Bernard Mbwele, Visha Tailor, Ervin Kocjancic and 2 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in International urogynecology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Efficacy of Sacrospinous Fixation or Uterosacral Ligament Suspension for Pelvic Organ Prolapse in Stages III and IV: Randomized Clinical Trial.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2023
    Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Female pelvic floor protection-Where do we have to go?Acta obstetricia et gynecologica Scandinavica · 2026
    Review
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Heidi W BrownDepartment of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, 1010 Mound Street, 4th floor, Madison, WI, 53715, USA. hwbrown2@wisc.edu.ORCID http://orcid.org/0000-0003-4870-8369
Aparna HegdeTata Center for Urogynecology and Pelvic Health, Cama Hospital, Grant Government Medical College, Mumbai, India.
Markus HuebnerDepartment of Obstetrics and Gynecology, Medical Center - University of Freiburg, Germany, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Hedwig NeelsFaculty of Medicine and Health Sciences, MOVANT, Antwerp University Hospital, Gynaecology and Urology, Belgium, University of Antwerp, Belgium, Antwerp, Belgium.
Hayley C BarnesDepartment of Obstetrics/Gynecology and Urology, Loyola University Chicago Stritch School of Medicine and Loyola University Medical Center, Maywood, IL, USA.
Gisele Vissoci MarquiniDepartment of Gynecology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Narmin MukhtarovaDepartment of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, 1010 Mound Street, 4th floor, Madison, WI, 53715, USA.
Bernard MbweleDepartment of Epidemiology and Biostatistics, Mbeya College of Health and Allied Sciences UDSM-MCHAS, University of Dar es Salaam, Mbeya, Tanzania.
Visha TailorDepartment of Urogynaecology, Imperial College Healthcare, London, UK.
Ervin KocjancicDepartment of Urology, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Elisa TrowbridgeDepartment of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, VA, USA.
Lynsey HaywardDepartment of Urogynecology, Middlemore Hospital, Auckland, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisThis narrative review describes the existing epidemiologic literature and identifies gaps regarding pelvic organ prolapse (POP) prevalence, incidence, natural history, and current and future service needs. MATERIALS AND

methodsA PubMed search identified relevant citations published in 2000 or later. Pre-specified criteria were used to screen titles, abstracts, and manuscripts, including reference sections. Study findings were summarized to define what is known, identify gaps in current knowledge, and suggest priority areas for future research.

resultsThe reported prevalence of POP varies widely (1-65%) based on whether its presence is ascertained by symptoms (1-31%), pelvic examination (10-50%), or both (20-65%). Most existing population-based surveys do not include physical examination data. White women from higher income countries are overrepresented in the existing literature. Incidence and natural history data are limited and consist mainly of cohorts that follow women after pregnancy or menopause. Given global increases in aging populations in well-resourced countries, the need for POP treatment is anticipated to increase in the coming decades. In lower and middle income countries (LMICs) where demographic trends are different, there is a dearth of information about anticipated POP service needs.

conclusionFuture POP incidence, prevalence, and natural history studies should include non-white women from LMICs and should combine pelvic examination data with validated patient-reported outcome measures when feasible. Anticipated future service needs differ globally, with a greater demand for POP treatment services in well-resourced settings where aging populations are prevalent.

Indexed as

Pelvic Organ ProlapseAgingFemaleHumansIncidencePregnancyPrevalenceReferral and ConsultationEpidemiologyIncidenceNatural historyPelvic organ prolapsePrevalence

Identifiers

PMID34977950

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.